Marijuana Derivative, Epidiolex, Reduces Seizures in Treatment-Resistant Epilepsy

Marijuana Derivative, Epidiolex, Reduces Seizures in Treatment-Resistant Epilepsy

A new study has found that cannabidiol (CBD), a medical marijuana derivative, was effective in reducing seizure frequency for patients with severe, treatment-resistant epilepsy.

The year-long study led by researchers at New York University (NYU) Langone Medical Center also found that CBD was well-tolerated and safe for most children and young adults.

Led by Orrin Devinsky, M.D., a professor of neurology, neurosurgery, and psychiatry and director of the Comprehensive Epilepsy Center at NYU Langone, the study took place at 11 epilepsy centers…

ORIGINAL SOURCE: Click Here to Continue Reading Article…